|
PHERECYDES PHARMA is the first and fully dedicated bio-defense and bio-security company in France based on a new disruptive technology platform to address first bacterial threats, next viruses, and then toxin threats
PHERECYDES PHARMA first development, is to introduce new products against multi-resistance bacteria, combining surveillance, detection and therapeutic tools based on phage technology.
Diversified libraries of bacteriophages are created by stochastic recombination of their targeting system, and biotechnological applications are derived, such as miniaturized biosensors and pharmaceutical applications.
Our
mission is to develop new tools to rapidly detect and treat people
and their environment against a large range of biothreat agents,
including multi-resistant, emergent or previously uncharacterized
bacteria.
The
diversity of our phage libraries allied to the exceptional properties
of bacteriophages allow us to address infectious problems in
biodefense, environmental hygiene, food safety, veterinary and human
therapeutics.
- Pherecydes-Pharma is a spin-off of Bio-Modeling Systems: www.bmsystems.net
Downloads & News
-
New: 12th annual NSTI Nanotech 2009 Houston USA. May 3-7, 2009. NSTI Nanotech is the world’s largest and most anticipated annual nanotechnology conference and expo. Dr. François Iris, is invited as Co-founder & CSO of Pherecydes-Pharma to present its innovative technologies at the Phage Nanobiotechnology symposium co-chaired by the MIT and the Auburn university.
|
